HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Per os administration of 5-fluorocytosine is effective in the regression of CD-expressing liver metastases in rats.

Abstract
The bacterial cytosine deaminase (CD) gene, associated to the 5-fluorocytosine (5-FC) prodrug, is one of the more widely used suicide systems in gene therapy. Introduction of the CD gene within a tumor induces, after 5-FC treatment of the animal, a local production of 5-fluorouracil (5-FU) resulting in intratumor chemotherapy. Destruction of the gene-modified tumor is then followed by the triggering of an anti-tumor immune reaction resulting in the regression of distant wild-type metastasis. In pre-clinical studies, 5-FC is generally administered by daily intraperitoneal injections. However, when used as an anti-fungal in humans, either IV or oral administration is used. In this study, we compared oral and intraperitoneal 5-FC administration in rats bearing a wild-type and a cytosine deaminase-expressing liver tumors. The results indicate that per os 5-FC administration is as efficient as intraperitoneal for the induction of CD-expressing tumor regression and the triggering of a distant bystander effect, acting on wild-type liver tumor and extra-hepatic metastasis.
AuthorsAdolfo Gavelli, Patrick Baqué, Nicole Brossettej, André Bourgeon, Pascal Staccini, Bernard Rossi, Valérie Pierrefite-Carle
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 14 Issue 2 Pg. 323-5 (Aug 2004) ISSN: 1107-3756 [Print] Greece
PMID15254786 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimetabolites
  • Cancer Vaccines
  • Flucytosine
  • Cytosine Deaminase
Topics
  • Administration, Oral
  • Animals
  • Antimetabolites (administration & dosage)
  • Cancer Vaccines (administration & dosage)
  • Cell Line, Tumor
  • Cytosine Deaminase (biosynthesis, genetics)
  • Flucytosine (administration & dosage)
  • Genetic Therapy (methods)
  • Infusions, Parenteral
  • Liver Neoplasms (drug therapy, pathology)
  • Lung Neoplasms (secondary)
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: